Good MorningEquity markets are hovering near all-time highs and look like they want to move higher. While the market wants to believe the FOMC when it says inflation spikes are temporary, it also looks like the market is waiting for the proof. That proof may come this week on Friday with the release of the PCE price index, the FOMCs preferred gauge of core consumer-level inflation. The PCE index is expected to show a strong gain from the previous month but at a slower rate than before. A hotter than expected number could spook the market.
Thursday's trading will be impacted by the weekly jobless claims figures, durable goods orders, a revision to the first-quarter GDP figures, and commentary from several Fed members. The GDP data is expected to be unrevised while jobless claims are expected to fall to a new post-pandemic low.
Featured: Sell these "safe" blue chips immediately (Ad) 
|
Communication Services | | With the sun shining and the evenings as long as they’re going to be for another year, there are few industries more suited towards the summer months than social media. People are out and about, meeting up, and keen to post about it. Inflation worries have receded compared to where they were b... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Markets | |
It’s important to take the emotion out of your investing decisions. And that’s a great starting point for a conversation about investing in precious metals.
There’s a lot of emotion about equities in 2021. Is inflation really a problem? If so, will the Federal Reserve raise in... Read the Full Story |
|
Consumer Discretionary | |
What is an investor to make of a stock that is well-supported by sell-side analysts but also heavily shorted?
For starters, we know that one side may be very right and the other very wrong. Stocks that meet both criteria are also likely to be quite volatile given the wide disparity of institution... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Consumer Staples | |
Beverage maker Splash Beverage Group (NYSEAMERICAN: SBEV) stock has recently been uplisted to the NYSE American exchange with a 1-for-3 reverse stock split on June 11, 2021, through an IPO of 3.75 million shares and warrants priced at $4 per share. The warrants are exercisable for one share of com... Read the Full Story |
|
Markets | |
Although the S&P 500 limped to the finished line on Wednesday, it managed to climb within less than a point of its record intraday high from last week. This week's rally has been rather broad based with all 11 sectors finishing green on Monday.
With the major indices near record levels, inves... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Consumer Discretionary | | Winnebago Industries (NYSE: WGO) saw strong sales and earnings growth during the pandemic, as Americans hit the road to enjoy the outdoors, away from cities.
As Covid restrictions eased ahead of the summer getaway season, that growth continued in the most recent quarter.
Early Wednesday, the comp... Read the Full Story |
|
Energy | |
Liquefied natural gas (LNG) development company NextDecade Corporation (NASDAQ: NEXT) stock has been breaking out on strength in the energy sector and notably midstream master limited partnerships (MLP). Despite the clean energy faction calling for the end of the fossil fuel industry, it’s h... Read the Full Story |
|
Consumer Discretionary | |
Follow The Money To Big Gains In The Second Half
With the second-quarter earnings season quickly approaching the analysts have begun re-evaluating their position on some of America's top brands. Based on what we're seeing, the quarter is shaping up to be another one that is better than the curren... Read the Full Story |
|
Markets | |
Have you enjoyed the bounceback on Wall Street since March 2020? Who hasn't?
However, experts at Moody's say we could be in for a market correction to the tune of a 10% to 20% pullback. The recovery may be slow as well — it could take a year to return to the break-even point.
So, what will... Read the Full Story |
|
Consumer Discretionary | | When you stop to think about the long-term trends that are shaping up to deliver the most winning stocks, the rise of e-commerce is at the top of the list. Internet shopping is one of the most popular online activities in the world, and the growth of the industry over the last few years has simply b... Read the Full Story |
|
The Early Bird Stock Of The Day Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland. | | View Today's Stock Pick |
|
